CMS Issues Initial Guidance for Medicare Drug Negotiation Program
- March 17, 2023
The Centers for Medicare & Medicaid Services (CMS) issued March 15 much-anticipated guidance providing industry stakeholders the first detailed look at how the agency plans to approach the new Medicare drug price negotiation program.
ARTICLE TAGS
You must be logged in to access this content.